Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04482920 · ClinicalTrials.gov registry record
Effect of Hormone Therapy on Renal Function
A clinical trial of Kidney Diseases and Kidney Injury, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 22
- Enrollment target
- 1
- Study location
NCT04482920: Completed study of Kidney Diseases and Kidney Injury, sponsored by University of Colorado, Denver.
NCT04482920 is a study of Kidney Diseases and Kidney Injury that has completed, run by University of Colorado, Denver. The registered enrollment target is 22 participants, below the 1,785-participant average among 38 other Kidney Diseases trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04482920, a study of Kidney Diseases and Kidney Injury, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to understand the effects of testosterone or estradiol on kidney function in transgender adolescents and young adults.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST p-aminohippurate clearance study
- DIAGNOSTIC_TEST Iohexol infusion
Study Locations (1)
Colorado
- Children's Hospital Colorado - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2021-04-15 |
| Est. Completion | 2023-08-31 |
What the finished NCT04482920 record still lists
NCT04482920 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,785-participant average among 38 other Kidney Diseases trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Kidney Diseases appearing as the primary indexed condition, and to 2 interventions - of which p-aminohippurate clearance study is the first listed.
NCT04482920 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT04482920 about?
NCT04482920 is a clinical study titled "Effect of Hormone Therapy on Renal Function". The purpose of this study is to understand the effects of testosterone or estradiol on kidney function in transgender adolescents and young adults.
What is the current status of trial NCT04482920?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2021-04-15. Estimated completion is 2023-08-31.
What conditions does trial NCT04482920 study?
This clinical trial studies the following conditions: Kidney Diseases, Kidney Injury, Transgenderism.
What interventions are being tested in trial NCT04482920?
The interventions under investigation include: p-aminohippurate clearance study (DIAGNOSTIC_TEST), Iohexol infusion (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04482920?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04482920 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04482920's enrollment target sits among peer trials
22 35th of 38 higher than 4 of 38 other Kidney Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collaborative Learning to Achieve Refined Interventions for Emory: Kidney Disease
RECRUITING · NA
-
Rutgers University Study of the Genetics of Kidney Disease
RECRUITING
-
Supporting VETerans With Kidney Disease Through Food As Medicine
RECRUITING · NA
-
Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients
RECRUITING · Phase 3
-
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
RECRUITING · NA
-
Dietary Intervention to Improve Kidney Transplant Outcomes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI